4/8
08:45 am
sls
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
Low
Report
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
3/20
04:05 pm
sls
SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
Low
Report
SELLAS Life Sciences Reports Full Year 2024 Financial Results and Provides Corporate Update
2/20
08:45 am
sls
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
Low
Report
SELLAS Announces Positive Data from Phase 2a Trial of SLS009 in Combination with Zanubrutinib in DLBCL
1/28
03:11 pm
sls
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
Medium
Report
SELLAS Life Sciences Group Announces $25 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
1/25
05:06 am
sls
Biotech CEO predicts 'revolutionary' steps toward curing cancer on horizon thanks to AI [FOX News]
High
Report
Biotech CEO predicts 'revolutionary' steps toward curing cancer on horizon thanks to AI [FOX News]
1/23
08:10 am
sls
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia
High
Report
SELLAS Life Sciences Announces Positive Outcome of Interim Analysis for its Pivotal Phase 3 REGAL Trial of GPS in Acute Myeloid Leukemia